journal article·2018-11-26

Squaric Acid-Coumarin-Chlorambucil: Photoresponsive Single-Component Fluorescent Organic Nanoconjugates for Self-Monitored Therapeutics

Amrita Chaudhuri, Yarra Venkatesh, Joyjyoti Das, Krishna Kalyani Behara, Smita Mandal, Tapas K. Maiti, N. D. Pradeep Singh

ACS Applied Nano Materials· Volume 1· Issue 11
Publisher page

Abstract

In this paper, we have developed photoresponsive fluorescent organic nanoconjugates based on a single-component system for effective cancer treatment by a synergistic combination of photodynamic therapy (PDT) and chemotherapy. Our single-component system was synthesized by coupling the squaric acid and the coumarin-chlorambucil conjugate. Next, multifunctional squaric acid-coumarin-chlorambucil (Sq-Cou-Cbl) nanoconjugates were prepared by “simple reprecipitation technique”. The unique properties of the newly designed Sq-Cou-Cbl nanoconjugates are (i) a phototrigger for controlled anticancer drug (chlorambucil) release and a photosensitizer for PDT upon visible light irradiation (ii) cellular imaging and self-monitoring of the drug release by a noninvasive fluorescent technique and (iii) PDT activity of the released photoproduct thereby resulting in the improved therapeutic efficiency. Further, in vitro studies showed that Sq-Cou-Cbl nanoconjugates exhibited an enhanced anticancer activity by synergistic cytotoxic effect of PDT and chemotherapy on HeLa cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. 10.1002/adma.20170632010.1002/adma.201706320 ↗
2. 10.4155/tde.10.1310.4155/tde.10.13 ↗
3. 10.1021/acsami.8b0111410.1021/acsami.8b01114 ↗
4. 10.1016/j.biomaterials.2016.08.01610.1016/j.biomaterials.2016.08.016 ↗
5. 10.1021/cm504566f10.1021/cm504566f ↗
6. 10.3390/cancers302259710.3390/cancers3022597 ↗
7. 10.1016/j.jconrel.2018.02.00110.1016/j.jconrel.2018.02.001 ↗
8. 10.1002/adma.20170483310.1002/adma.201704833 ↗
9. 10.1021/acsami.8b0826910.1021/acsami.8b08269 ↗
10. 10.1039/C8SC02305K10.1039/C8SC02305K ↗
11. 10.1021/acs.biomac.8b0060710.1021/acs.biomac.8b00607 ↗
12. 10.1021/acsanm.8b0057210.1021/acsanm.8b00572 ↗
13. 10.1021/acsami.5b1119710.1021/acsami.5b11197 ↗
14. 10.1002/adma.20160386410.1002/adma.201603864 ↗
15. 10.1039/C4MD00481G10.1039/C4MD00481G ↗
16. 10.1016/j.pdpdt.2018.03.00610.1016/j.pdpdt.2018.03.006 ↗
17. 10.1021/am500965n10.1021/am500965n ↗
18. 10.1021/nn501073x10.1021/nn501073x ↗
19. 10.1021/acsami.7b0902510.1021/acsami.7b09025 ↗
20. 10.1039/C5PP00057B10.1039/C5PP00057B ↗
21. 10.1111/j.1751-1097.1997.tb01925.x10.1111/j.1751-1097.1997.tb01925.x ↗
22. 10.1021/ja075933a10.1021/ja075933a ↗
23. 10.1016/j.snb.2017.01.00810.1016/j.snb.2017.01.008 ↗
24. 10.1246/bcsj.71.259710.1246/bcsj.71.2597 ↗
25. 10.1021/la051183b10.1021/la051183b ↗
26. 10.1021/jm400025g10.1021/jm400025g ↗
27. 10.1039/C5TB02563J10.1039/C5TB02563J ↗
28. 10.1021/jm401214210.1021/jm4012142 ↗
29. 10.1139/v95-20010.1139/v95-200 ↗
30. 10.1039/a802740d10.1039/a802740d ↗
31. 10.1021/acs.jchemed.5b0048310.1021/acs.jchemed.5b00483 ↗
32. 10.1021/j100550a01010.1021/j100550a010 ↗
33. 10.1021/acs.orglett.7b0041610.1021/acs.orglett.7b00416 ↗
34. 10.1021/acs.joc.6b0215210.1021/acs.joc.6b02152 ↗
35. 10.1039/b201081j10.1039/b201081j ↗
36. 10.1016/S1572-1000(05)00007-410.1016/S1572-1000(05)00007-4 ↗
37. 10.1021/jp071521c10.1021/jp071521c ↗
38. 10.1002/adhm.20170127210.1002/adhm.201701272 ↗
39. 10.1158/1078-0432.CCR-08-155810.1158/1078-0432.CCR-08-1558 ↗